glp-1 agonist gila monster Science's 2023 Breakthrough: GLP-1R Agonists Gila Monster Venom: The Unexpected
Description
Eur J Pharmacol (2011) 650(1):24955
doi: 10.1016/j.celrep.2017.03.005
Efficacy and safety of once-weekly glucagon-like peptide 1 receptor agonist albiglutide (HARMONY 1 trial): 52-week primary endpoint results from a randomized, double-blind, placebo-controlled trial in patients with type 2 diabetes mellitus not controlled on pioglitazone, with or without metformin
48,49 Heart Rate Increase GLP-1RAs are known to cause a modest, dose-dependent increase in resting heart rate
Among these, Retatrutide has garnered attention for its unique...
Both GLP-1RAs and tirzepatide demonstrated efficacy in improving circulatory lipid profiles in the large clinical trials (199, 200)
